- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lee Schwartzberg Reflects on the First Year of OneOncology
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Transcript
Looking back on the first year of OneOncology, how has the partnership impacted both providers and patients?
The first year of OneOncology has been a tremendous growth opportunity for us as we’ve learned our core practices and we’ve learned how the patients flow and how the operations piece works, so we’ve now integrated a lot of the functions, particularly on the operational side so that there’s this smooth and consistent way operations are being done and the technology has been aligned.
We have the same OncoEMR system for our [electronic health record], we have the same billing system now the same revenue cycle management, enterprise management. So that now is standardized and we’re now focusing on the clinical piece, and we’ve spent a lot of time over the last 6 months figuring out where the pressure points are on our clinical enterprise and how we bring the practices together.
One of the things that’s been amazing to be is there’s so much excitement and so much expertise that varies from our practices and bringing all that together elevates all of our practices. So, we’re working now on pathways and we hope to hope a unified pathway component going forward into 2020. We’re very excited about a research network that we’ve heard from all of our partners is really important so that we can improve clinical access to clinical trials and to have more trials participate. There’s so many great drugs being evaluated now, we just need more access and we’re hearing from our manufacturers, we’re hearing from our practices, we’re hearing from patients, “Give us more opportunities,” so that’s a high priority for us in the next year as we move forward.
We’re working on a whole number of quality and value initiatives and each of these are a committee that we formed as part of our overarching leadership council called OneCouncil. Soo, we’ve established the operational piece now in the first year and moving full force into the clinical piece.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
